NCT02227472 Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease Status COMPLETED Phase N/A
NCT02225132 Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02222246 Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease Status COMPLETED Phase PHASE4
NCT02200510 Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease Status COMPLETED Phase NA
NCT02197845 Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators Status COMPLETED Phase NA
NCT02193191 Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02187445 Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial Status COMPLETED Phase PHASE1
NCT02179359 Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Status TERMINATED Phase NA
NCT02151526 A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02149537 Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment Status COMPLETED Phase PHASE4
NCT02140554 A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02133560 Use of Mobile Technology for Intensive Training in Medication Management Status COMPLETED Phase NA
NCT02105766 Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02098993 Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome Status TERMINATED Phase PHASE2